Analyst Actions on Chinese Stocks: BORN, CEA, CEO, CHBT, CTRP, HOLI, JST, SINA, WX (Aug 3, 2010)

Below are today’s Analyst Actions on U.S.-Listed Chinese Stocks.

Cowen and Company initiated coverage of China New Borun Corp (NYSE:BORN) with Outperform rating. Citigroup maintained Buy rating and HK$5 price target on the Hong Kong-listed shares of China Eastern Airlines Corp. Ltd. (NYSE:CEA). Daiwa reiterated Outperform rating on CNOOC Limited (NYSE:CEO), and maintained HK$15.40 price target on the company's Hong Kong-listed shares. Roth Capital Partners maintained Buy rating and $20 price target on China-Biotics Inc. (NASDAQ:CHBT). Susquehanna Financial Group maintained Neutral rating on Ctrip.com International, Ltd. (NASDAQ:CTRP). Roth Capital Partners maintained Hold rating on Hollysys Automation Technologies Ltd (NASDAQ:HOLI), and cut price target from $11 to $10.50. Roth Capital Partners maintained Buy rating and $18 price target on Jinpan International Limited (NASDAQ:JST). Credit Suisse reiterated Outperform rating on SINA Corporation (NASDAQ:SINA), and cut price target from $51 to $50.1. Oppenheimer & Co. maintained Perform rating on SINA Corporation (NASDAQ:SINA). Bank of America reiterated Buy rating and $19 price objective on WuXi PharmaTech (Cayman) Inc. (NYSE:WX). Piper Jaffray reinstated Neutral rating on WuXi PharmaTech (Cayman) Inc. (NYSE:WX), with $16 price target. Jefferies & Company upgraded WuXi PharmaTech (Cayman) Inc. (NYSE:WX) from Hold to Buy, and maintained $18 price target.